PARP1, BRCA1 and androgen receptor expression in triple-negative breast cancer patients treated with neoadjuvant chemotherapy Hayam E. Rashed; Randa E. Monged; Nashwa Nawar; Ahmed Z. Alattar; Ahmed A. Alnagar; Mohamed I. Abdelhamid; Osama Abdelaziz; Nelly M. Said;

Predictive value of tumor-infiltrating lymphocytes (TILs) and programmed cell death-ligand 1 (PD-L1) expression in breast cancer patients treated with neoadjuvant chemotherapy Hayam E. Rashed; Shireen S. Muhammad; Reham Sameh; Eman Elsebai; Nashwa Nawar; Mohamed I. Abdelhamid; Lobna A. Abdelaziz;

Cáncer de mama: nueva clasificación molecular Manuel García-Redondo; Ángel Pareja López; Nuria López Ruiz; Juan Manuel Rodríguez Alonso;